Stand Up 2 Cancer, in collaboration with the American Association for Clinical Research, will be funding innovative research grants with a potential to further translational cancer research.
Stand Up to Cancer (SU2C), in collaboration with the American Association for Cancer Research, has announced funds to the tune of $7.5 million made available to inovative work in the field of cancer research. This amount will be evenly distributed between 10 scientists as an Innovative research Grant (IRG) over a period of 10 years.
"IRGs offer financial support to independent, early-career scientists pursuing novel, high-risk, high-reward cancer research proposals that have significant potential for translation to clinical application and hold great promise for advancing SU2C’s overarching goal of improving and saving lives," says the associated press release.
The deadline for applicant's letter of intent is November 13, 2015.
Read more at http://bit.ly/1QlAZYz.
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen